Sickle Cell Disease and Increased Hemolysis. When to Consider Evaluating for A Concurrent Hereditary Hemolytic Condition (213-2)
10:15 am – 10:45 am
Friday, September 16
Sickle Cell Disease is an inherited red blood cell disorder that can lead to increased hemolysis which can result in significant anemia. When a child with sickle cell disease does not respond to therapies or interventions designed to decrease hemolysis, then a provider may want to consider the presence of a concurrent inherited hemolytic process such as G6PD, Hereditary Elliptocytosis or Gluthathione reductase deficiency.
This presentation will involve the review of each of the aforementioned inherited hemolytic process in a child with sickle cell disease. Each case will involve a review of clinical course, laboratory values, response to therapies/interventions to help reduce degree of hemolysis, as applicable, as well as the testing for and implication(s) of a concurrent inherited hemolytic process in a child with sickle cell disease. A brief overview of the incidence and pathophysiology of the three inherited hemolytic states will also be provided to the learner. This presentation will be co-presented by an APRN and a Genetic Counselor in effort to increase awareness of concurrent inherited hemolytic processes in the setting of sickle cell disease.
Tagged under
- Advanced Level
- Hematology
- General Clinical Practice
- Advanced Practice
- Concurrent Session
- ILNA Category: Psychosocial
- ILNA Category: Disease Related Biology
- ILNA Category: Care of the Pediatric Hematology and Oncology Patient
- ILNA Category: Symptom Management
- ILNA Category: Palliative Care
- ILNA Category: Supportive Care
- ILNA Category: Professional Practice
- ILNA Category: Professional Performance
- Total ILNA Points: 0․5
Related items
- Professional Development Session: Professional Development GPS: The Long and Winding Road from Route 1 to Route 101 (CDE)
- General Session: APHON Advocacy: Ask, Tell, Ask (104)
- The Future of Nursing 2020-2030: What We All Need to Know (224)
- Pediatric Anticoagulation: Who, What, When, Where, and Why (and a little How) (225)
- Nutritional Support: Best Practices for Pediatric Blood and Marrow Transplant Patients (226)
- Speaker(s):
- CNE Hours:
- .5